David Zaccardelli | Chief Executive Officer |
Mark Hahn | Chief Financial Officer |
Kathy Rickard | Chief Medical Officer |
Christopher Martin | Senior Vice President of Commercial |
Andreas Argyrides | Wedbush |
Andrew Tsai | Jefferies |
Edward Nash | Canaccord Genuity |
Thomas Shrader | BTIG |
Boobalan Pachaiyappan | H.C. Wainwright |
Welcome to Verona Pharma Second Quarter 2023 Financial Results and Operating Highlights Conference Call. At this time all participants are in listen-only mode. Earlier this morning, Verona Pharma issued a press release announcing its financial results for the 3-months ended on June 30th, 2023. A copy can be found in the Investor Relations tab on the corporate website, www.veronapharma.com.
Before we begin, I’d like to remind you that during today’s call, statements about the company’s future expectations, plans and prospects are forward-looking statements.